Keywords: |
histopathology; review; cancer recurrence; cisplatin; doxorubicin; multimodality cancer therapy; combined modality therapy; lymph node dissection; lymph node excision; carboplatin; etoposide; lung resection; antineoplastic combined chemotherapy protocols; lung neoplasms; tumor markers, biological; cyclophosphamide; tumor marker; vinblastine; cancer size; testicular neoplasms; dactinomycin; bleomycin; teratoma; neoplasms, germ cell and embryonal; mediastinum; germ cell tumor; mediastinal neoplasms; seminoma; non seminomatous germinoma; alpha fetoprotein; chorionic gonadotropin; retroperitoneal space; dysgerminoma; human; male; priority journal; support, non-u.s. gov't; support, u.s. gov't, p.h.s.
|